SCHEMBL6320162

SCHEMBL6320162

CC1(C)COP(=O)(C(=Cc2ccc3c(c2)CC(=O)N3)CNc2cnc3ccccc3c2)OC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 5/20 0.35
TDP2 O95551 1/20 0.35
IRAK4 Q9NWZ3 2/20 0.34
JAK3 P52333 1/20 0.34
RAB9A P51151 3/20 0.33
LMNA P02545 2/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
RPS6KA3 P51812 1/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
CDC7 O00311 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6320852 0.69 TDP2 (0.37) PTK2TDP2IRAK4JAK3RAB9A
SCHEMBL6317759 0.68 OPRM1 (0.38) PTK2TDP2IRAK4JAK3RAB9A
SCHEMBL6325709 0.68 PTK2 (0.37) PTK2TDP2IRAK4JAK3RAB9A
SCHEMBL6324395 0.66 BRD4 (0.35) PTK2TDP2IRAK4JAK3HDAC6
SCHEMBL6319893 0.65 PTK2 (0.35) PTK2TDP2IRAK4JAK3RAB9A
SCHEMBL6317290 0.64 FGFR1 (0.35) PTK2TDP2IRAK4JAK3PTK2B
SCHEMBL6325670 0.62 KDR (0.38) RAB9ALMNAPOLBHSD17B10RPS6KA3
SCHEMBL6317821 0.62 KDR (0.39) RAB9ALMNAPOLBTSHRHSD17B10
SCHEMBL6317753 0.61 IGF1R (0.58) PTK2CDK2KDRPTK2B
SCHEMBL6319622 0.61 KDM4E (0.44) RAB9ALMNANPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US claimed
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US disclosed
US-20050101675-A1 Benzamidine derivatives and process for production thereof TEIJIN LIMITED (JP) 2005-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels APOB, LDLR, LPL PTK2 1567/4885TDP2 3606/4885IRAK4 3405/4885
US-20050101675-A1 Benzamidine derivatives and process for production thereof AOC2, TALDO1, AOC1 PTK2 4500/4885TDP2 4582/4885IRAK4 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.